VOYA Investment Management
ABUS icon

VOYA Investment Management’s Arbutus Biopharma ABUS Stock Holding History

VOYA Investment Management’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$151K Buy
31,473
+2,797
+10% +$12.3K ﹤0.01% 2295
2026
Q1 		$129K Sell
28,676
-673
-2% -$2.94K ﹤0.01% 2168
2025
Q4 		$141K Hold
29,349
– – ﹤0.01% 2211
2025
Q3 		$133K Sell
29,349
-13,799
-32% -$50.7K ﹤0.01% 2256
2025
Q2 		$133K Buy
43,148
+1,625
+4% +$5.4K ﹤0.01% 2417
2025
Q1 		$145K Sell
41,523
-4,534
-10% -$15.1K ﹤0.01% 2352
2024
Q4 		$151K Sell
46,057
-2,460
-5% -$9.05K ﹤0.01% 2476
2024
Q3 		$187K Sell
48,517
-749
-2% -$2.87K ﹤0.01% 2502
2024
Q2 		$152K Buy
49,266
+4,361
+10% +$13.1K ﹤0.01% 2556
2024
Q1 		$116K Sell
44,905
-11,388
-20% -$29.5K ﹤0.01% 2600
2023
Q4 		$141K Sell
56,293
-82,678
-59% -$162K ﹤0.01% 2677
2023
Q3 		$282K Buy
138,971
+13,240
+11% +$27.8K ﹤0.01% 2341
2023
Q2 		$289K Buy
125,731
+83,523
+198% +$217K ﹤0.01% 2385
2023
Q1 		$128K Hold
42,208
– – ﹤0.01% 2656
2022
Q4 		$98.3K Hold
42,208
– – ﹤0.01% 2758
2022
Q3 		$80.6K Hold
42,208
– – ﹤0.01% 2828
2022
Q2 		$114K Buy
42,208
+11,271
+36% +$28.8K ﹤0.01% 2581
2022
Q1 		$92K Hold
30,937
– – ﹤0.01% 2521
2021
Q4 		$120K Sell
30,937
-905
-3% -$3.52K ﹤0.01% 2637
2021
Q3 		$137K Hold
31,842
– – ﹤0.01% 2671
2021
Q2 		$96K Buy
+31,842
New +$98.6K ﹤0.01% 2776
2019
Q2 		– Sell
-13,404
Closed -$48K – 2581
2019
Q1 		$48K Hold
13,404
– – ﹤0.01% 2511
2018
Q4 		$51K Hold
13,404
– – ﹤0.01% 2485
2018
Q3 		$127K Hold
13,404
– – ﹤0.01% 2456
2018
Q2 		$98K Buy
+13,404
New +$79.8K ﹤0.01% 2524

Other funds holding ABUS

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

VOYA Investment Management's ABUS Position: Q2 2026 in Review

VOYA Investment Management increased its Arbutus Biopharma (ABUS) stake by 9.8% in Q2 2026, buying an estimated $12.3K and bringing the position to 31,473 shares worth $151K. The position accounts for ﹤0.01% of the portfolio, ranked #2295.

VOYA Investment Management first reported a position in ABUS in Q2 2018 and has held it in 25 quarters since. The position peaked at $289K in Q2 2023. 176 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

  • VOYA Investment Management held 31,473 shares of Arbutus Biopharma worth $151K as of Q2 2026.
  • VOYA Investment Management bought 2,797 Arbutus Biopharma shares in Q2 2026, an estimated $12.3K.
  • Arbutus Biopharma made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2295 holding.
  • VOYA Investment Management first reported a position in Arbutus Biopharma in Q2 2018 and has held it in 25 quarters since.
  • VOYA Investment Management's Arbutus Biopharma position peaked at $289K in Q2 2023.
  • 176 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.